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ABSTRACT 
Background: Previous work has shown that follicular dendritic cells (FDCs) play an 
important role in selecting B cells such that antigens are responded to in a specific 
manner. FcγRΙΙB (CD32) is an antibody constant-region receptor found on FDCs and 
mutation of this receptor in humans is associated with Systemic Lupus Erythematosus 
(SLE). In addition, previous work has demonstrated that autoreactive germinal centers 
are the product of expression of interferon alpha (ΙFNα) by FDCs, so FcγRIIB signaling 
may involve modulation of IFNα signaling.  
Objective: Because FcγRIIB mutation is associated with SLE and FDCs have been 
shown to be important in orchestrating B cell responses, understanding FcγRIIB on FDCs 
helps characterize B cell repertoire development in response to antigen—whether the 
antigen is foreign or self, as is the case in autoimmunity. Better characterization of the 
role of FcγRIIB could have consequences for autoimmune and cancer therapy. This study 
seeks to determine the role of FcγRΙΙB on FDCs in germinal center B cell selection 
dynamics within single, autoreactive germinal centers. 
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Methods: This study compares transplanted wild-type (B6) B cells—that are driven to be 
autoimmune by simultaneously transplanted autoimmune B cells—in two stromal cell 
settings: first, in germinal centers containing wild-type FDCs and second, in germinal 
centers containing FcγRIIB-knockout FDCs. Transplanted B6 B cell populations express 
photoactivatable protein, which allows for sorting of B cells from individual germinal 
centers. B cell sequences from single germinal centers were analyzed to determine how 
focused each germinal center response was and how the B cells differ in maturity and 
affinity for antigen. Finally, mice expressing a lineage-tracing system were treated with 
IFNα in order to observe the cytokine’s effect on B cell selection. 
Results: Cells sorted from germinal centers containing FcγRIIB-knockout FDCs contain 
a distinguished population of less-developed B cells, as quantified by population-based 
analysis of their variable heavy chain genes. Overall, the IgM sequences from B cells 
sorted from germinal centers (GCs) containing FcγRIIB-knockout follicular dendritic 
cells displayed lower levels of somatic hypermutation (SHM) (p<.05) and shorter 
hypervariable regions (CDR3) (p<.05) compared to other B cell populations. Values 
computed to summarize how many different B cell lineages were present in a GC—its 
“clonality”—did not vary between the two mouse populations, although FcγRIIB-
knockout FDC germinal centers displayed a correlation between clonality and 
immunoglobulin (Ig) isotype expression (R2= .85). Finally, lineage tracing mice receiving 
injections of interferon alpha (IFNα) displayed no difference in GC clonality compared to 
those receiving vehicle and assays of IFNα downstream signaling genes also displayed no 
change. 
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Conclusions: FcγRIIB encourages more stringent selection of immature B cells in 
germinal centers as evidenced by survival of less developed B cells as defined by degree 
of somatic hypermutation and CDR3 length in GCs comprising FcγRIIB-knockout FDCs. 
In spite of this, sequence-based measures of germinal center clonality as completed here 
may fail to capture the functional results of B cell selection. In addition, the link between 
FcγRIIB and IFNα requires further investigation.	
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INTRODUCTION 
 
Systemic Lupus Erythematosus  
 
Overview of Impact 
 Autoimmune diseases are estimated to affect 23.5 million individuals in the 
United States (US department of Health and Human Services, 2017)—which translates to 
1 in every 13 people in the US in 2018. The director of the National Institute of Allergy 
and Infectious diseases estimated, in 2001, that the annual economic burden of 
autoimmune diseases was 100 billion dollars. These statistics are on the scale of cancer, a 
disease that is widely known for its large impact globally and in the U.S: 12.5 million 
individuals are estimated to be affected by cancer in the US, associated with an estimated 
cost of 124 billion for the year of 2010 (Yabroff et al, 2011).  
 Systemic Lupus Erythematosus (SLE) is an autoimmune disorder that is estimated 
to affect 250,000 individuals in the United States (Tsokos et al., 2011). Based on 
estimates of direct costs ($3,735–$14,410) per individual per year and indirect costs 
($1,093–$14,614) per individual per year (Reviewed in Zhu et al, 2011) the estimated 
annual cost of SLE is between 1.2 and 7.3 billion dollars per year. This places SLE in the 
same range of cost per year as certain common cancer types. For instance, an estimated 
11.9 billion dollars are spent yearly on prostate cancer (Yabroff et al, 2011).  
 SLE incidence is highest among women—only about 4-22% of those affected are 
male (Sthoeger et al, 1987, Miller et al 1983, Lahita et al, 1983, Kaufman et al, 1989, 
Font et al 1992, Aydintug et al, 1992, A. Gedalia et al, 1999, Ward et al, 1990). Within 
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racial/ethnic groups, the incidence has been shown to be significantly higher among black 
than white individuals, with rates of incidence being between 7.9 to 9.4 versus 3.2 to 3.7 
individuals per 100,000 people (Lim et al 2014, Somers et al, 2014). Rates among Native 
Americans/Alaskan Natives has been found to be 7.4 per 100,000. (Ferruci et al, 2014).  
 The prognosis for SLE has improved dramatically within the past 30 years, going 
from a 4-year survival rate of 50% in the 1950’s (Merrell & Shulman, 1955) to a 92% 
survival at 10 years in 2003 (Cervera et al, 2003). However, incidence of SLE has nearly 
tripled in the last 4 decades (Gabriel et al, 2009), although some increase in incidence 
may be attributable to more recent studies having wider access to patient records. 
Improved prognosis is encouraging but the increasing incidence demands continued 
investigation.  
Disease Pathogenesis 
 
 The cause of lupus appears to be a combination of genetic predisposition and 
environmental factors. Previous studies have demonstrated a concordance of 25% 
between monozygotic twins and 2% between dizygotic twins which demonstrates that 
there is a genetic component to the disease but that this does not automatically result in 
disease (Sullivan, 2000). Known environmental factors associated with SLE are UV light 
exposure (Tan et al 1982) and Epstein Barr Virus, the DNA of which was found in 100% 
of patients in one study (James et al, 1997, other causes reviewed in Tsokos et al., 2011). 
Ultimately, it has been confirmed that a very important component of the pathogenesis of 
SLE is the presence autoantibodies towards double-stranded DNA (Isenberg et al, 2007). 
Such antibodies are specific to SLE, with one study showing that 70 of lupus patients 
	 3	
possess these autoantibodies compared to less than 1 percent in the control population 
which included other autoimmune diseases.  
 Of the genetic predispositions, several genes have been identified, including genes 
for major histocompatibility complexes and for constant region immunoglobulin 
receptors (Namjou et al, 2007, Wakeland et al, 2001). While SLE pathogenesis involves 
many parts of the immune system, pathogenesis is intimately tied to abnormal B cell 
function (Shlomchik et al., 1994). Past research has established an important role for 
follicular dendritic cells in organizing the B cell response, as FDCs present antigen to B 
cells (Maclennan et al., 1994, Tarlinton & Smith, 2000) and their presence is required for 
the existence of germinal centers (Wang et al., 2011). Of the constant region 
immunoglobulin receptors, only one, FcγRIIB, is expressed on follicular dendritic cells 
(van Nierop, 2002). This study seeks to establish the role of FDC-expressed FcγRIIB in 
autoimmunity because these cells are important in orchestrating humoral immunity and 
mutation of this receptor—the only Fc receptor on FDCs—is associated with SLE 
(Rahman and Isenberg, 2008).  
B cell selection in germinal centers  
 
Germinal centers 
 
 Germinal centers arise as a vital part of T-independent humoral responses, in 
which B cell activation requires interaction with CD4 T cells. In this type of humoral 
response, B cells expressing BCRs with high affinity for the antigen internalize the 
antigen, degrade it, and present it on MHC class II molecules on the cell surface. A 
cognate CD4 T cell expressing a TCR with affinity for this antigen may then bind TCR to 
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the B cell MHCII-displayed antigen and this leads to proliferative signaling for the B cell. 
There has been scientific debate as to whether this T-B interaction or the original 
encounter with antigen—whether in native form or on FDCs—is limiting of B cell 
selection. (Maclennan, 1996, Victora et al., 2010). This process is contrasted from the T-
dependent humoral responses, in which larger antigens with repeating epitopes or 
sufficiently strong antibody-epitope affinity can activate a B cell without further 
interaction with CD4 T cells (Gulbrainson-Judge & Maclennan, 1996).  
When B cells are activated by this linked recognition, they begin proliferating in 
primary foci within secondary lymphoid organs, followed by formation of germinal 
centers on day 4 after first antigen exposure (Kerfoot et al, 2011). Germinal center 
reactions are vital to the T-dependent humoral immune response as this is where B cells 
undergo processes that ensure their reactivity to antigen. Studies have also suggested that 
GCs may also represent a checkpoint against generation of autoreactive BCRs (Cappione 
et al., 2005). 
Diversity and affinity of B cells in germinal centers 
  
 B cells must be able to react to a wide range of epitopes with high affinity in order 
to confer effective humoral immunity. In order to achieve a wide range of recognition, 
individual B cells alter their own genes for parts of their BCR in two processes: somatic 
recombination and somatic hypermutation.  
 Somatic recombination occurs while B cells are developing in the bone marrow. 
During somatic recombination, V(D)J recombinase acts on the loci for both the heavy 
and light chain for the BCR, joining together combinations of V (variable), D (diversity), 
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and J (junctional) gene segments. The gene segments put together by V(D)J recombinase 
produce combinatorial diversity as it takes place independently in each B cell within an 
organism (Early et al, 1980). Further junctional diversity is contributed by the relative 
nucleotide position in which the V, D, and J segments come together (Weigart et al., 
1980) (Figure 1). This highly junctionally diverse region comprises the third 
complementarity determining region (CDR3) Within this region, the diversity is 
increased by several orders of magnitude by the addition and removal of further 
nucleotides in the spaces between gene segments within CDR3 (Komori et al., 1993).   
 
Figure 1. Visual description of VDJ recombination. Initial BCR repertoire 
combinatorial diversity is achieved through stepwise combination of D, J, and V gene 
segments being somatically joined together to create permanently altered germline DNA. 
This initial combination of gene segments is often used, such as in the present study, to 
define B cells of a given lineage. Adapted from Janeway et al, 2001. Janeway CA Jr, 
Travers P, Walport M, et al. Immunobiology: The Immune System in Health and Disease. 
5th edition. New York: Garland Science; 2001. The generation of diversity in 
immunoglobulins. Available from: https://www.ncbi.nlm.nih.gov/books/NBK27140/ 
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 After the original diversification of BCRs from somatic recombination, somatic 
hypermutation and affinity maturation occur once the B cell expresses AID in a germinal 
center. AID acts on the rearranged V gene to produce single nucleotide mutations which 
results in B cell clones with slightly different V genes and therefore antigen affinities 
(Pham et al, 2003). B cells are then selected within the germinal center through affinity 
maturation, a process through which B cells undergo somatic hypermutation and those 
expressing mutations for higher-affinity BCRs continue proliferation (Jacob et al, 1991, 
Anderson et al, 2009, Kelsoe et al., 1996). AID also controls the process of class-switch 
recombination. This is the process by which B cells which have been selected for 
expression of high affinity antibody then somatically recombine the genetic loci coding 
for the constant chain of their antibody. This is how immunoglobulin isotypes beyond 
IgM are produced (Muramatsu et al., 2000).  
 The present study seeks to explore the impact of FDC-expressed FcγRIIB on 
affinity maturation because this is a stage in which there is evidence for selection against 
self-reactive B cells (Cappione et al., 2005). Furthermore, there is some evidence that 
FDCs play a role in deletion of autoreactive clones during this phase of the humoral 
response (Yau et al, 2013). In mouse models in which self-tolerance is broken, it has been 
shown that the GC response can promote not only the affinity maturation of autoreactive 
BCRs, but epitope spreading, in which autoreactive BCRs with high affinities for other 
self-antigens are selected for (Degn et al, 2017).    
The FDC-B cell relationship in autoimmunity  
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  Previous work has demonstrated the importance of CD21/CD35 in the education 
of B cells by FDCs, showing that the inability of FDCs to trap immune complexes using 
these complement receptors leads to diminished humoral responses (Barrington et al 
2002). Further work has linked CD21/CD35 internalization of self-antigen in lupus model 
mice to TLR7 signaling, IFNα release, and development of autoreactive B cells. (Das et 
al 2017). It is well-established that IFNα plays an important role in lupus; the cytokine 
has been shown to be elevated in the disease (Rönnblom et al., 2006). While FcγRIIB is 
another receptor capable of responding to antigen surrounding FDCs and known to be 
mutated in many lupus patients (Rahman and Isenberg, 2008), less is known about its role 
in orchestrating the B cell response. Knowing that CD21 internalization of self-antigen 
leads to proliferation of self-reactive B cell clones in autoimmune mouse models, the 
present study seeks to elucidate the role of FcγRIIB in this same autoimmune context. 
FcγRIIB 
 
 Immunoglobulin constant region receptors (FcRs) act as an important regulator of 
the immune system because they are present on many types of immune cells and 
influence how these cells respond to an ongoing humoral response (Jefferis et al., 1995). 
FcRs which bind the immunoglobulin G isotype (FcγRs) balance humoral responses 
because their presence on different cells can cause opposing signaling cascades. One can 
imagine that FcγRs expressed on this array of immune cells, universally coupled to 
activating signaling, could produce a never-ending, over-reactive response to IgG. This is 
not the case, because different subtypes of FcγR on different immune cells are coupled to 
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either inhibitory or activating signals in a way that balances the immune response 
associated with IgG production (Nimmerjahn & Ravetch, 2008).  
 
The low affinity immunoglobulin gamma Fc region receptor II-b, FcγRIIB, is an 
inhibitory receptor found expressed on most effector cells including B cells, 
macrophages, dendritic cells, neutrophils, and mast cells, but not on T or NK cells 
(Ravetch & Bolland, 2001, Hulett & Hogarth, 1994). The downstream signaling as a 
result of result of receptor engagement on FDCs has not been clearly established. 
Whereas FcγRIIB engagement on B cells, for example, leads to inhibitory signaling, it 
has not been clearly established what the functional result of FcγRIIB engagement on 
FDCs is.  
It has been demonstrated that mice lacking FcγRIIB displayed higher levels of B 
cells producing poly and autoreactive antibodies (Tiller et al., 2010) but such studies 
observe the effect of the removal of the receptor from all cells. It has also been shown 
that mice lacking FcγRIIB trap lower levels of immune complexes and have impaired 
antibody production (Qin et al., 2000). Both of these studies have examined mice in 
which all cells are lacking FcγRIIB but further work must be done to understand the 
receptor’s function on specific cells. When FcγRIIB is knocked out specifically from B 
cells, this observation of higher levels of autoreactive antibodies is also observed (Li et 
al., 2014) which is attributed to the established inhibitory signaling that FcγRIIB 
engagement on B cells produces (Reviewed in Ravetch et al., 2001). Because FDCs play 
a role in B cell selection and this receptor has been shown to trap immune complexes for 
	 9	
recycling on FDC surface (Heesters et al., 2013), further study of FcγRIIB on FDC 
surface is well-warranted.  
Investigating the role of FcγRIIB on FDCs using autoreactivity-driving Ig and 
photoactivatable germinal centers 
 SLE can be modeled in mice by generation of transgenic B cells that express 
antibodies with high affinity for nucleic acid material. In nonautoimmune mice, 
autoreactive B cells in germinal centers are excluded from proliferation through a variety 
of mechanisms (Goodnow et al 2005) but in lupus mouse models, this self-tolerance is 
broken. Previous studies have shown that murine expression of 564 Ig, a transgenic BCR 
reactive to nucleic acid material, break tolerance and begin producing autoantibodies 
(Berland et al 2006). This model has been used to further study the mechanism of 
autoimmunity: it has now been observed that, once tolerance is broken, these 564 
antibodies drive germinal centers to select for wild-type B cells expressing BCRs with 
high affinity for related self antigens. (Degn et al 2016). This is an ideal, reliable lupus 
model for studying affinity maturation in autoreactive germinal centers because the 
observations can be made on wild-type B cells. In the present model, bone marrow 
harvested from mice heterozygous for the 564 knockin was used as part of mixed bone 
marrow transplants in order to produce autoreactive germinal centers.  
 Isolation of single germinal centers relies on photoactivatable germinal center 
cells as established by Victora et al., 2010. Thus the other component of the mixed bone 
marrow transplanted into the murine populations in this study is bone marrow expressing 
the photoactivatable reporter, PA-GFP.  
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 Concurrent experiments prompt the present investigation of BCR sequences from 
individual germinal centers. Germinal centers were imaged at several time points using B 
cells transgenically expressing lineage-reporting fluorescent colors (nicknamed 
“Confetti”) in the context of FDCs either expressing or lacking FcγRIIB. The Confetti 
lineage-tracing system, addressed in more depth later in this study, allows study of B cell 
dynamics in germinal centers because B cell clones display 1 of 10 unique fluorescent 
colors. As GC selection proceeded in mice either wild-type or knockout for FcγRIIB, 
imaging of GCs and analysis of color distributions revealed that GCs with FcγRIIB-
knockout FDCs became more diverse over time relative to FcγRIIB-inact FDC GCs. 
(Data not shown). This result may suggest a less-stringent selection process in GCs where 
FDCs do not possess FcγRIIB, but sequence-level analysis is necessary to appreciate the 
true effects of this receptor on GC B cell selection. The change in GC color diversity is a 
good gauge of GC selection stringency but it lacks the precision of sequencing. A clear 
picture of the selection effects on B cell lineages cannot be appreciated by this color-
labeling, which does not assign a unique color to each clone—but it can be appreciated 
on the sequence level because BCR sequences are as unique as the functional protein they 
encode.   
 Prior to the work of the current study, mixed bone marrow chimeric mice were 
created in order to isolate FcγRIIB absence to FDCs. A portion of transplanted bone 
marrow contained transgenic, autoreactive 564 Ig in addition to the bone marrow cells 
expressing the photoactivatable reporter. Expression of the photoactivatable reporter 
allows individual germinal centers to be precisely photoactivated. These photoactivated 
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GC B cells were sorted from single germinal centers and their BCRs were sequenced. 
Additional work carried out in the present study expanded this dataset of BCR sequences 
from single germinal centers to include control sequences from naïve, wild-type B cells 
sorted from lymphoid follicles. Computational analysis of these sequences was 
undertaken to elucidate the role of FcγRIIB on FDCs in autoreactive germinal center B 
cell selection. The present study also examines the link between FcγRIIB on FDCs and a 
cytokine previously shown to drive autoreactive B cell proliferation, IFNα (Das et al., 
2017).   
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SPECIFIC AIMS 
A vast amount of work has been devoted to characterizing the pathogenesis and 
treatment of systemic lupus erythematosus. However, there is limited understanding of 
the function of FcγRIIB on follicular dendritic cells, despite this being the only antibody 
constant region receptor on these cells which have been shown to be intimately involved 
in orchestrating the B cell response—and despite this being a gene for which many lupus 
patients possess mutation (Wakeland et al. 2001). Previous work has shown that 
complement receptors on follicular dendritic cells play an integral role in internalizing 
self antigens and spurring autoreactivity by TLR7 signaling and IFNα production (Das et 
al 2016). Furthermore, it has been established that autoreactive B cells can drive germinal 
centers to become autoreactive once tolerance is broken and drive epitope spreading 
within germinal centers (Degn et al 2017). Understanding FcγRIIB signaling in 
autoreactive germinal centers is needed, as is further understanding of the dynamics of 
clonal selection in germinal centers in these autoreactive contexts. It is on this basis that 
this study aims to: 
1. Determine whether the presence of FcγRIIB on FDCs confers more stringent 
selection of B cells in GC reactions.  
2. Determine whether an influence on B cell selection by FcγRIIB on FDCs is 
correlated with modulation of the IFNα signaling in autoreactive germinal 
centers.  
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METHODS 
Overview 
 
 The present study undertook two main experimental directions: 1) studying the 
sequences of single B cells from single germinal centers and 2) evaluating the impact of 
IFNα injections on germinal center B cell selection. The following methods are thus 
organized accordingly.  
 
Methods for studying single-cell sequences: 
 
Generation of mixed bone marrow chimeric mice 
 
All mouse methods were completed in compliance with local IACUC standards of 
care. Bone marrow chimeric mice were prepared based on previously published work as 
found in Degn et al., 2017. C57/Bl-6 mice (4 males) and FcγRIIB-knockout mice (1 
female, 2 males) were irradiated with 1000 rad and immediately placed on water with 
dissolved antibiotics (sulfamethoxazole/trimethoprim) to prevent opportunistic infections 
while bone marrow was being reconstituted. Femurs and tibias were extracted from bone 
marrow donors. In this case, bone marrow donors were PA-GFP and 564 +/- mice on 
C57/Bl-6 background. These bones were mechanically cleaned and rinsed through 
several rounds of HBSS supplemented with 10 mM HEPES, pH 72, 1 mM EDTA and 
2% heat-inactivated FBS (BM buffer). The bones were subsequently crushed in a mortar 
and the cell extract was passed through a 70 µm cell strainer (Corning). An aliquot was 
subjected to RBC lysis and counted in a standard hemacytometer (Neubauer chamber). 
Based on cell counts, appropriate ratios of the mixed BM were calculated to achieve the 
target donor ratios. In this case, donor ratio was 2:1 cells transgenically expressing 
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photoactivatable GFP:564+/- cells. Cells were then pelleted with centrifugation at 200g 
for 5 minutes and resuspended at 200 million cells per mL and 100 µL was then injected 
intravenously into each recipient 10-12 hours post irradiation. 
Photoactivation of single germinal centers, sorting of photoactivated B cells 
 
Spleen and LNs were harvested at time points as described in the Results section. 
For photoactivation, thin longitudinal or transversal sections of either 1 or 2-3mm, 
respectively, were made. These samples were placed in FACS buffer (PBS, pH 7.2, 1 
mM EDTA and 2% heat-inactivated FBS) in vacuum grease chambers over which 
coverslips were placed. Imaging was performed on an Olympus FV1200 MPE 
multiphoton system microscope fitted with either a 20X 0.95NA Plan water-immersion 
objective or a 25X 1.05NA Plan IR optimized water-immersion objective, a MaiTai HP 
DeepSee Ti-Sapphire laser (Spectraphysics), and 4 non-descanned detectors (2 GaAsP 
and 2 regular PMTs). Imaging of PA-GFP explants was performed at l = 930-940 nm, 
photoactivation was performed at l = 830 nm.  
 Single cell generation of cDNA, Sanger sequencing 
 
 Reverse Transcriptase generation of cDNA 
 
  Single B cells sorted on the basis of paGFP by FACS from digested 
splenic sections as described above  were stored in individual wells of 96-well plates at -
80˚C. eleven µL of room-temperature Agencourt RNAClean XP beads, A63987 were 
added to each well and plate was incubated on magnet. Supernatant was removed. The 
plates were then washed in this way 3 times with 80% ethanol. Plates were air dried for 
10 minutes and reverse transferase reactions were initiated once beads visibly began 
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cracking. The first mix (0.5 µL anchored OligodT20 from Invitrogen (2.5 µg/µL), 0.125 
µL RNase inhibitor, 1 µL of 10mM dNTP, 2.875 µL of H2O) was added to each well and 
the plate was centrifuged briefly and incubated for 3 minutes at 72 ˚C followed by 1 
minute on ice. Then the second mix (2 µL 5x Reverse Transcriptase buffer, 0.25 µL 
RNase inhibitor, 0.1 µL Maxima H-RT (200U/µL), 1 µL 5 M Betaine, 1.2 µL 25mM 
MgCl2, 1.55 µL H2O ) was added to the same wells. Plates were then centrifuged briefly 
again and placed on a thermocycler for 1 hour at 50 ˚C.  
  Single Cell PCR 
  Plates containing the 10 µL cDNA and beads in the wells were diluted 
five-fold using 40 µL of autoclaved MilliQ water. 5 µL of this mixture was then used per 
PCR reaction. PCRs were completed in semi-nested fashion: first, a longer nucleotide 
sequence length was amplified before then amplifying an inner length. The mix for the 
outer rounds of PCR was, added to the five µL of cDNA and beads, 8.5 µL of H2O, 4 µL 
of 5x buffer, 0.4 µL 10 mM dNTP, 1.2 µL MgCl2, 0.4 µL primer MsVHE, 0.4 µL of the 
outer primer relevant to either µ, γ, or κ sequencing, and 0.1 µL of Taq. The second round 
of PCR utilized 1 µL of the product from the first round of PCR and then the following 
mix: 12.5 µL H2O, 4 µL 5x buffer, 0.4 µL 10mM dNTP, 1.2 µL MgCl2, 0.4 µL of 
MsVHE, 0.4 µL of primer for the inner stretch of sequence, and 0.1 µL Taq. From these 
20 µL reactions, 2-5 µL were run on agarose gels and the rest was precipitated by 
addition of 1/10th volume 3 M sodium acetate (pH 5.2) and 2.5 volumes 96% ethanol. 
After incubation at -20˚C overnight, samples were spun at 3,500 rpm for 30 minutes. 
Supernatant was discarded by flicking and pellet was washed in 70% ethanol. Pellets 
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were then dried and resuspended in water. With a template concentration of 5 ng/µL and 
a primer concentration of 0.4 pmol/µL (primer used was always the applicable primer for 
the inner, semi-nested sequence), samples of 12 µL volume were submitted to DFCI 
Sequencing core.  
Methods for studying germinal center diversity 
 
Tamoxifen Induction, Intraperitoneal injections of IFNα 
 
Recombination of the Rosa26 Confetti allele in Aid-CreERT2 mice was induced by 
a single gavage of 15 mg of tamoxifen dissolved in sunflower oil at 30 mg/mL. 
Tamoxifen gavage was administered to mice and first injections began four days later. 
Mice were injected intraperitoneally with either 1.25 µg of IFNα (BioLegend) or PBS. 
Following tamoxifen induction and immunization, spleens and mesenteric LNs were 
harvested. Mesenteric LNs were placed on coverslip and placed on ice until imaging 
using the multiphoton microscopy setup previously described. Imaging of Confetti alleles 
was performed using l = 940 nm excitation. Fluorescence emission was collected in three 
channels, using the following filter sets: a pair of CFP (480/40 nm) and YFP (525/50 nm) 
filters, separated by a 505 nm dichroic mirror, for CFP/GFP/YFP detection, and a third 
filter (605/70 nm) for RFP detection. 
Sequence Analysis 
 
  Many processes involved in analyzing the single germinal center B cell sequences 
utilized tools developed in previous work while others required creating new tools. In all 
cases, the organization of the sequences in a by-germinal-center fashion necessitated 
creation of automated programs in order to execute the same protocol iteratively on 
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sequences from each germinal center. Several automation scripts were also built for 
analyses not mentioned in this paper. A summary of automated scripts pipeline is 
presented in Figure 2.   
 Processing sequences for analysis 
 Sequences obtained from the DCFI sequencing core were first manually curated 
by observation of Sanger sequencing chromatogram. Then sequences were processed 
using automated operation of the FASTX toolkit 
(http://hannonlab.cshl.edu/fastx_toolkit/). Sequences were converted to single-line .fasta 
file format, clipped to remove the inner sequence primers, and converted to the reverse 
complement sequence in order to be reading from 5’ to 3’. Before sequences were 
included in the dataset, they were hand-curated on the basis of their chromatogram: 
sequences in which unidentifiable nucleotides occurred within the VH sequence were 
removed.  
  Using IgBlast to match Query Sequences with a Reference Database 
 
Sequences were submitted to IgBlast against the full NCBI V(D)J dataset with 
standard settings (Ye et al., 2013). Query using IgBlast produces .txt files containing 
information on identified V, D, and J segments as well as nucleotide sequences of each 
segment and number of nucleotide mismatches between each segment and its best-
matched germline nucleotide sequence. The totaled number of mismatches discovered 
occurring between the identified Framework 1 and Framework 3 regions were considered 
in analyses of nucleotide mutation levels. The output files were both imported to 
Microsoft Excel for analysis of clonality as well as processed into more comprehensive 
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data files using a script built for the present study.  
Statistical analysis 
Calculation of clonality index based on sequences from single germinal 
centers 
To measure the degree to which single germinal centers were “focused”, in terms 
of the number of B cell lineages present, the clonality index was calculated based on the 
V gene segment identified by IgBlast. The proportion of U productive BCR clonotypes i 
was defined as: 
𝑝" = 	 𝒏"𝒏"&"'(  
Meaning that ni is the count of productive reads of the clonotype i where i = 
1,2,…,U. Using the count of productive reads for each clonotype, the diversity, D, is 
calculated based on the normalized Shannon entropy (Shannon et al., 1948, Robins et al., 
2009) given by:  
𝑫 =	− 𝒑𝒊𝑙𝑜𝑔0𝒑𝒊𝑙𝑜𝑔0(𝑼)&"'(  
Finally, the clonality index (CI) as used in the present study is defined as the 
complement of diversity. CI = (1-D). This means that higher values of clonality index 
indicate germinal centers that contain a low number of unique clones and lower values of 
clonality index indicate germinal centers that contain a high number of unique clones. 
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This method for calculating the clonality index was adapted from Zhu et al., 2015.  
 
  
	
Figure 2. Overview of computational analysis. Curated Sanger sequences were 
processed, submitted in IgBlast queries, and IgBlast output was analyzed using 
automation scripts built using Python.  
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RESULTS 
Single Cell BCR Sequencing Dataset 
 
 Mixed bone marrow chimera mice were necessary to study the role of FcγRIIB on 
FDCs specifically. This receptor is located on a variety of cells, including B cells, but the 
only known cells of mesenchymal origin that expresses FcγRIIB are FDCs (Cyster et al., 
2000). Thus, a mouse with FcγRIIB absent only from FDCs must be obtained by 
irradiating its bone marrow and replenishing it with bone marrow comprising cells that 
possess the receptor. The components of the mixed bone marrow were important to the 
present study. One third of transferred bone marrow comprised B cells with a transgenic 
564 nucleic acid recognizing BCR. Previous studies have demonstrated that these 
transgenic autoreactive B cells can break tolerance in germinal centers such that there is a 
sustained proliferation of autoreactive cells that are derived from wild type origin (Degn 
et al., 2017). The other two-thirds of the transferred bone marrow comprised B cells 
expressing photoactivatable GFP (PA-GFP). Previous work has shown that the GFP on 
cells in these single germinal centers can be photoactivated with narrow resolution and 
single photoactivated cells may then be sorted on this marker (Victora et al., 2010). Using 
these methods, bone marrow chimera mice were created and B cells were sorted from 
splenic single germinal centers in December 2016 (Figure 3).  
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Figure 3. Methods for obtaining single germinal sequences from mixed bone 
marrow chimeric mice. Overview of experimental approach used to obtain single cell 
sequences from single germinal centers of mixed bone marrow chimera mice. (See 
Methods).  
 
 
Heavy chain BCR DNA sequences were obtained from seven mixed bone marrow 
chimera mice and two naïve wild type mice (Table 1) in order to study B cell selection in 
germinal centers on a single cell level (Table 2).  	
Table	1.	Summary of Single Germinal Center Murine Experiments 
Population B6 (control, 
follicular B cells 
pooled, n= 84) 
B6 Bone Marrow 
Recipients 
FcγRIIB-knockout 
Bone Marrow 
Recipients 
Mice 2 4 3 
Photoactivated 
germinal centers 
with cells 
submitted to 
sequencing 
N/A 16 9 
Germinal centers 
with > 10 curated 
sequences 
N/A 9 6 
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Table	2.	Summary of Single Cell Sequencing Dataset 
Population:#Cu
rated Sequences 
Isotype populations: # Curated Sequences 
Total:455   
WT Follicular: 
84 
WT Follicular IgM: 84  
Bone Marrow 
Chimeras: 371 
  
B6 Bone 
Marrow 
Recipients: 193 
B6 Bone Marrow Recipients, 
IgM: 64 
B6 Bone Marrow Recipients, 
IgG: 128 
CD32 -/- Bone 
Marrow 
Recipients: 178 
CD32 -/- Bone Marrow 
Recipients, IgM: 39 
CD32 -/- Bone Marrow 
Recipients, IgG: 139 		
Important V gene segments are expressed differently in the absence of CD32 on 
FDCs 
 
The NCBI database for mus muscularis VH sequences was queried with VH 
sequences obtained from the two bone marrow chimera groups using IgBlast (Ye et al., 
2013). IgBlast is used to identify the germ line reference V, D, and J gene segments, and 
if possible, common reference CDR3 nucleotide sequences. V usage within the B6 and 
FcγRIIB-knockout bone marrow recipient mice was further broken down by isotype—
IgG and IgM—in order to include the dynamics of class-switching in this analysis.  
 Germline V gene segment usage does not appear to vary between the isotype 
populations from the chimeric mice, at least not in any pattern correlated with the lineage 
of the reference V gene segment nucleotide sequences. Within both the B6 and FcγRIIB-
knockout recipient mice groups, the V gene segment repertoires vary between the non-
class-switched IgM and the IgG. Notably, certain V gene segments (VHQ52.a27.79, 
J558.22.112) that were found in large numbers in previous studies of autoreactive 
germinal centers and associated with autoimmunity (Degn et al., 2017) are found in both 
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populations. J558.22.112 is found to be most prevalently within the mice possessing 
FcγRIIB-knockout FDCs and a close relative V gene segment, J558.16.106, is also highly 
utilized (Figure 4).  
	
Figure 4. V Cassette Usage Within Isotype by Mouse Population. Values in blue 
correlate with the usage frequency of a given V gene segment in a given BCR population. 
Associated lineages described by the cladogram were calculated using reference germline 
sequences in the NCBI database.  
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FcγRIIB-Knockout FDC Germinal Centers Display Spectrum of Responses 
 
Another analysis using the V gene segments identified by IgBlast was carried out, 
as described in Zhu et al, to describe the degree to which the single germinal centers from 
the chimeric mice were “focused” in terms of the number of B cell lineages within them. 
A higher Clonality Index indicates a GC comprising B cells of a smaller number of 
progenitors. In this study, cells from the single germinal centers of the bone marrow 
chimeras that express the same V gene segment are considered to be of the same ancestor.  
Whether or not the FDCs expressed CD32 did not have an impact on the average 
clonality index of the germinal centers. Both B6 and FcγRIIB-knockout mouse 
populations displayed clusters of low and high-clonality germinal centers, and further 
investigation revealed that this bimodal distribution within the FcγRIIB-knockout 
population correlated with the mice from which the germinal center was obtained (Figure 
5A).   
A further simple analysis of the proportion of IgG+ B cells in these germinal 
centers also revealed no observed difference between the two bone marrow chimera 
populations. However, the same bimodal distribution within the population of mice 
possessing FDCs lacking CD32 was revealed (Figure 5B). These two analyses were 
summarized with a linear regression between the two variables—clonality index and % 
IgG. The population with FDCs possessing CD32 showed very weak correlation (R2=.08). 
However, within germinal centers from the knockout population, the clonality index and 
the percent of sequences coding for IgG were strongly correlated (R2 = .85) (Figure 5C).  
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Figure 5. FcγRIIB-Knockout FDC Germinal Centers Display Spectrum of 
Responses. A) Clonality Index calculated as by Zhu et al for each germinal center in B6 
and CD32-/- recipient single germinal center populations. Mouse number is indicated in 
the colored legend. B) The Percent IgG within germinal centers from each of the same 
populations. C) Linear Regression analysis for the isotype proportions versus the 
clonality index of the two populations. R2 for B6 Bone marrow recipients = 0.084, R2 for 
CD32 bone marrow recipients = .8505. 
 
Absence of FcγRIIB on FDCs prompts lower SHM within IgM-expressing germinal 
center B cells. 
Another critical process occurring in GCs is the affinity maturation of B cells 
(Jacob et al, 1991, Anderson et al, 2009, Kelsoe et al., 1996). To investigate whether this 
process is perturbed in the absence of FcγRIIB on FDCs in an autoimmune context, 
sequences from the FcγRIIB-knockout bone marrow recipients were analyzed to compare 
the degree of somatic hypermutation being carried out by AID.  
  Compared to naive, follicular B cells sorted from the spleens of wild type B6 
mice, cell populations from chimeric mice display a higher degree of nucleotide mutation 
when their heavy chain V gene is compared to a matched reference germline V gene from 
the NCBI dataset. Notably, IgM sequences from the FcγRIIB-knockout bone marrow 
recipients display fewer nucleotide mutations in this gene region compared to IgG 
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sequences from mice of the same chimeras and compared to both isotypes from germinal 
centers with intact FcγRIIB on FDCs (Figure 6A).  
 Population based analysis yielded a clearer description of a population of IgM-
expressing B cells in the FcγRIIB-knockout mouse population in which no SHM had yet 
occurred within the V gene segment (Figure 6B). This is striking in comparison to the 
distribution of mutations within V gene segments of IgG, where the distributions in both 
populations are more similar (Figure 6C) and the wild-type pool of naïve B cells, which 
logically have experienced very little or no somatic hypermutation (Figure 6D).  
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Figure 6. FcγRIIB-Knockout FDCs Allow Survival of Less-Developed IgM-
Expressing B Cells. Mutation analysis as a gauge for degree of somatic hypermutation in 
B cell subpopulations from each bone marrow recipient population. Number of 
nucleotide mismatches occurring within the FR1 to FR3 regions of a given query 
sequence when compared to its best match in the NCBI reference database from A) Each 
population: IgM+, IgG+, and naive, follicular B cells. (**** p <.0005, ** p<.05, multiple 
pairwise ANOVA). Panels B-D represent relative frequencies of each number of 
indicated nucleotide mutations occuring within the FR1 to FR3 regions of a given query 
sequence compared to best-matching NCBI reference sequence:  B) ΙgM+ sorted B cells 
viewed as a histogram C) IgG+ sorted B cells D)  naïve, wild-type follicular B cells.  
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 Previous studies have established that the number of N nucleotide additions to the 
CDR3 region of a BCR is correlated with autoreactivity (Volpe & Kepler, 2009). Using 
IgBlast to match the query VH sequences from the B6 and FcγRIIB-knockout bone 
marrow recipient mice yielded matches for the germline V, D, and J gene segments 
somatically expressed by each B cell. This search also identifies the nucleotide sequence 
within the VH where the three gene segments have come together to form a CDR3. A 
simple translation of these nucleotide sequences in the right reading frame yielded the 
length of this region which was then compared between chimeric populations within both 
IgG and IgM isotypes.  
 Overall CDR3 length compared between populations reveals that those sequenced 
from FcγRIIB-knockout mixed bone marrow recipient mice possess, on average, IgM 
with shorter CDR3 lengths compared to the other 3 populations (Figure 7A). IgG CDR3s 
demonstrated bimodal distributions within both bone marrow chimera populations. It is 
also important to note the normal distribution of CDR3 lengths—and lower average 
CDR3 length overall—within the naive follicular wild-type B cell group (Figure 7A,D). 
 IgM CDR3’s display strikingly different length distributions within the two bone 
marrow recipient populations. Within the B6 bone marrow recipient IgM sequences, the 
distribution of CDR3 lengths from wild type bone marrow recipients occurred over a 
higher range as compared to sequences from FcγRIIB-knockout bone marrow recipients 
(Figure 7C).  
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 These data demonstrate the presence of a population of IgM within germinal 
centers containing CD32-/- FDCs that continues to survive that is less prevalent within 
the IgM sequences from wild-type FDC germinal centers.  
 
 
Figure 7. Short CDR3 IgM-Expressing B Cells Observed in Context of FcγRIIB-
Knockout FDCs. Analysis of length of amino acid sequence determined to be CDR3 by 
IgBlast. A) Length (#AA’s) of CDR3 sequences from each population. B) Length (#AA’s) 
of CDR3 sequences from both bone marrow chimera IgG populations arranged by 
frequency of sequences of a given length. C) Length (#AA’s) of CDR3 sequences from 
both bone marrow chimera IgM populations arranged by frequency of sequences of a 
given length. D) Length (#AA’s) of CDR3 sequences from wild-type, naïve, follicular B 
cell populations arranged by frequency of sequences of a given length. 
 
 Further analysis clarifies the distribution of VH sequences across the two 
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within the identified V gene) and the CDR3 amino acid chain length. Based on this 
analysis, it is clear that IgM sequences from FcγRIIB-knockout bone marrow recipients 
generally possess both lower degrees of SHM and shorter CDR3 lengths compared to the 
other populations sequenced. Additionally, this analysis reveals that, within the 
sequenced IgG VH regions from FcγRIIB-knockout bone marrow recipients, the longer 
CDR3 regions also tend to have greater numbers of nucleotide mutations (Figure 8).  
 
Figure 8. CDR3 length/degree SHM of VH sequences for each isotype population. 
Depth of color indicates number of cells with a given number of nucleotide mismatches 
found within FR1 to FR3 when a query sequence is compared to the best-matching 
reference sequence from the NCBI reference database using IgBlast and a given CDR3 
length (in #AAs translated in correct reading frame), as identified by IgBlast.  
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Intraparietal IFNα injection does not contribute to difference in GC diversity, 
downstream mx1 expression 
It has been reported that FDCs in lupus models take up self antigens through 
CD21 and, through TLR7 signaling, promote autoimmunity by producing IFNα (Das et 
al., 2017). However, the link between IFNα signaling and B cell selection is not well 
understood—and it also has not been explored how FcγRIIB signals relate to this 
established pathway.  
In order to investigate the effect of IFNα on GC B cell selection, mice with 
fluorescently labeled B cell lineages were used. Aid-CreERT2 Confetti mice were injected 
with IFNα intraparitoneally and observed at the 14-day time point with multiphoton 
microscopy (Figure 9). 
 
Figure 9. IFΝα Administration to Aid Cre Confetti Mice. Summary of methods 
utilized to obtain germinal center diversity values for mice receiving intraperitoneal 
IFNα. (See Methods).  
 
Aid-CreERT2 Confetti mice contain germinal center B cells (Aid-expressing) which, 
upon receiving a tamoxifen gavage, express 1 of 10 fluorescent color combinations (Tas 
et al., 2016). Observing these fluorescent GC B cells can provide information about the 
germinal center dynamics and the selection process latent in a given germinal center. 
Over time, a theoretically stringent selection process can be expected to yield a germinal 
center in which a strong majority of B cells share fluorescent coloring (Figure 10A). A 
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theoretically lenient selection process, on the other hand, is liable to produce germinal 
centers of diverse fluorescent colors in more equal proportions (Figure 10B).  
At the end of two weeks of injection, no difference was observable between mice 
that had received administrations of vehicle and mice that had received IFNα (Figure 
10C). As a quantification of successful administration of IFNα to target immune sites, 
downstream Mx1 expression was quantified by qPCR. Mx1 is a known downstream gene 
upregulated in response to IFNα. No difference in Mx1 expression was detectable (Figure 
10D).  
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Figure 10. IFNα Injection Does not Influence Germinal Center Selection. Germinal 
centers from Aid-CreERT2 Confetti mice observed at 14 days post-tamoxifen gavage after 
intraparietal injection with either IFNα or vehicle. A) Example germinal center 
demonstrating high diversity as evidence of lenient B cell selection. B) Example germinal 
center demonstrating low diversity as evidence of stringent B cell selection. C) The 
frequency of most dominant clone in each germinal center of Aid-CreERT2 Confetti mice 
treated with either IFNα or vehicle (.1M PBS). D) Μx1 expression within the two mouse 
groups quantified by qPCR. Values plotted represent the normalized CT values.   
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DISCUSSION 
 The purpose of this study was to explore the impact of follicular dendritic cell-
expressed FcγRIIB on B cell maturation in single, autoreactive germinal centers. It was 
hypothesized, at the outset of experimentation, that FcγRIIB on follicular dendritic cells 
serves a role to focus germinal reactivity on a narrower range of epitopes based on 
knowledge of internalization of immune complexes to non-degradative compartments for 
self-display (Heesters et al., 2013) and the traditional theories that B cells compete for 
antigen displayed on FDCs (Maclennan et al, 1994, Tarlinton & Smith, 2000). The 
hypothesis of the present study was that FcγRIIB serves to restrict the proliferation of B 
cells in autoreactive germinal centers —and therefore, absence of this constant region 
antibody receptor on follicular dendritic cells was hypothesized to create an elevated 
germinal center B cell clonal diversity. Furthermore, it was hypothesized that such an 
elevated diversity might be attributable to the expression of IFNα in such germinal 
centers. The results of this study do not prove or disprove the relationship between IFNα 
and increased germinal center clonal diversity but they do support the hypothesis that 
FcγRIIB serves to restrict the proliferation of B cells in autoreactive germinal centers.  
New model: FcγRIIB engagement inhibits proliferative signaling, leading to more 
stringent affinity maturation in autoreactive germinal centers 
 In analyses of nucleotide mismatches and CDR3 length, the IgM sequences 
obtained from FcγRIIB-knockout bone marrow recipient germinal centers demonstrated a 
population of strikingly low-SHM, short-CDR3 cells. Because the degree of SHM is 
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associated with antibody affinity (Kocks & Rajewsky, 1988) and longer CDR3 lengths 
are associated with higher degrees of autoreactivity (Wardemann, 2003, Larimore et al., 
2012), it is likely that these non-mutated, short IgM have low affinity for the self antigens 
being selected for in 564 Ig-driven, autoreactive germinal centers. The presence of these 
cells in germinal centers orchestrated by FcγRIIB-knockout FDCs—but relative absence 
in germinal centers containing wild-type FDCs—supports the hypothesis that FcγRIIB on 
FDCs functions to restrict the proliferation of less-reactive B cell clones.  
 While the present study did not prove or disprove the link between IFNα signaling 
and germinal center B cell selection, the proposed model of FcγRIIB on FDCs in 
autoreactive germinal centers is based on previous studies which have shown a 
relationship between IFNα signaling and autoreactivity (Das et al., 2017, Vollmer et al., 
2005). On this basis and the finding of the current study that less-reactive B cells can 
persist in germinal centers with FcγRIIB-knockout FDCs, this study proposes that 
engagement of FcγRIIB on FDCs serves to restrict germinal center B cell selection, 
potentially by downregulating IFNα or upstream signal (Figure 11).  
 The results of the present study are additionally significant because of the 
contribution they make to the ongoing exploration of B cell activation in T-dependent 
humoral immunity. In lymphoid follicles, B cells may acquire antigen either in its native 
form or from FDCs and then may receive proliferative signaling from cognate T cells 
(Gulbranson-Judge, 1996). The dynamics of the germinal center response have produced 
scientific debate, largely over which component ultimately limits the proliferative signal 
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of B cells undergoing affinity maturation in the germinal center. The classical theory was 
that B cell maturation is limited by access to antigen on FDCs (Tarlinton & Smith, 2000, 
MacLennan, 1994). However, some recent research has raised the question of whether T 
cell help is the limiting factor for B cell proliferation. Significantly, experiments have 
demonstrated that, when antigen is delivered directly to B cells, the access to T cell help 
is a limiting factor for B cell proliferation (Victora et al, 2010). This article offered 
evidence for B cells being limited by T cell interaction, but further research on FDCs 
remains warranted because the FDC-B cell was circumvented in these experiments. 
Because the current study shows differing persistence of B cells based on the state of 
their associated FDCs, the results here support the notion that FDCs play an important 
role in limiting affinity maturation.  
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Figure 11. Proposed model of FDC FcγRIIB involvement in autoreactive germinal 
centers. The observation of distinct populations of less-developed B cells in germinal 
centers containing FcγRIIB-knockout FDCs when compared with those containing wild-
type FDCs suggests that this receptor on the FDC may downregulate the IFNα signaling 
which previous studies demonstrated supports the survival of B cells normally selected 
against (Das et al., 2017).  
Discrepancy between sequence-based and functional measures of clonal dynamics 
 While these studies tend to suggest the survival of less-reactive clones in the 
FcγRIIB-knockout bone marrow recipient mice, this result is not observable within the 
Current understanding
Proposed involvement of FcγRIIB
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analysis of clonality index. If germinal centers orchestrated by FDCs lacking FcγRIIB 
allow a high number of low-reactivity B cell clones to survive, it might be expected that 
the clonality of these germinal centers would be significantly lower. This expectation is 
based on the assumption that these less-reactive populations are a diverse group of cells 
because their BCRs may not be selected for in any functional sense. However, analysis of 
clonality index does not show this phenomenon and germinal centers from both mouse 
populations display the similar average clonalities. This raises the question of the 
functional significance of the less-reactive IgM surviving in FcγRIIB-knockout bone 
marrow recipients: why does the presence of this population not lead to lower measures 
of clonality in germinal centers of this group? 
 The most likely line of reasoning is simply that the way clones were defined for 
the calculation of clonality index in this study is a crude way of doing so. In other words, 
this study’s criteria for considering B cells to be clonally related may not capture the 
nuanced physical differences in BCRs that would define B cell clones in a functional 
sense. Clones were defined as BCR sequences sharing a V gene segment. The main 
reason that this may pose too crude an approximation is that this discards information 
about competition within B cell clones. Previous studies have demonstrated that, while 
the competition between B cell lineages is an important aspect of the maturing humoral 
response, so is competition within lineages (Jacob et al., 1991, Tas et al., 2016). B cells 
with the same V segment and different amino acid mutations are considered clones by the 
present study, despite the fact that these functional differences may mean that these cells 
compete for proliferation. Other lineage tracing methods such as Aid-CreERT2 Confetti 
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mice, combined with sequencing, have been able to capture this intraclonal competition 
(Tas et al., 2016) and could prove an extension of the current study.  
Limited effectiveness of IFNα administration method 
 The other set of experiments in the present study were not able to prove or 
disprove the relation of the cytokine IFNα to germinal center diversity. The lack of 
difference in germinal center diversity between the two treatment groups that was 
revealed might conclusively disprove a relationship between IFNα and GC diversity, but 
further analysis of downstream Mx1 expression by splenic tissue undermines this lack of 
significance. The similar Mx1 expression in both treatment groups suggests that IFNα 
was not influencing signaling at the time the tissue was sampled. There are two potential 
reasons these results were obtained: improper dosage and improper timing. If the IFNα 
was administered and eliminated quickly, this could explain the identical Mx1 expression 
between both treatment groups. Even if only quickly available to B cells in germinal 
centers, it’s possible that the rapidly decaying IFNα could exert an influence on GC 
selection, observable by the confetti lineage tracing, but not on Mx1 expression. Too low 
a dose of IFNα, however, could easily explain the lack of difference in both measures. 
 Based on the observation that Mx1 expression did not differ between treatment 
groups, it can be concluded that IFNα was not acting in splenic tissue at the time of 
sampling. While it is inconclusive whether IFNα exerted an effect on GC selection before 
diminishing, further optimization studies must be carried out to ensure that IFNα is 
delivered properly to GCs.  
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Future Directions 
In addition to further optimization of experiments to determine the FcγRIIB-
mediated signaling which counteracts complement-mediated IFNα-signaling, the logical 
next step from this study is to further investigate this subpopulation within GCs bearing 
FcγRIIB-knockout FDCs. While the evidence presented by this study indicates the 
presence of a distinct group of less-selected IgM-expressing B cells in context of 
FcγRIIB-knockout FDCs, further research is warranted to confirm 1) whether these cells 
are new arrivals to these germinal centers or simply old cells that are not very active and 
2) whether these cells can manifest epitope spreading. In order to further characterize the 
germinal center dynamics of this subpopulation, further work can be done to repeat these 
mixed bone marrow chimera experiments, but utilizing a system in which germinal center 
B cells are induced to express a fluorescent molecule and sorted and sequenced at later 
and later time points. Another, more challenging analysis which could provide a clearer 
idea of the state of these specific competing B cells would be to pair whole-genome RNA 
sequencing with the Sanger B cell sequencing on each cell in order to evaluate their 
transcriptional state.  
The other major question which remains to be addressed is whether the 
persistence of these B cells has implications for epitope spreading. Autoreactive germinal 
centers in which several B cell lineages are selected for by affinity maturation are 
associated with epitope spreading (Degn et al., 2017). Epitope spreading can be a major 
concern for lupus patients. For example, nephritis, a major problem associated with 
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lupus, has been shown to arise when autoantibodies evolve to also react to proteins in the 
kidney (Mostoslavsky et al., 2001, Zhao et al., 2005). To study this question, it could be 
worthwhile to extend the present study by expressing a subset of the antibodies from each 
murine population and expose them to antigen arrays. The previously discussed methods 
capable of perceiving intraclonal competition are more experimentally intensive but 
could yield a clearer idea of the competition dynamics.  
 In conclusion, the present results reveal persistence of less-developed B cells in 
the GCs containing FcγRIIB-knockout FDCs. Further work can be done to elucidate the 
transcriptional state and dynamics of these B cells as well as the signaling mechanism 
through which FcγRIIB may oppose the previously established, complement-mediated 
IFNα-driven B cell proliferation. 
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